Inventor · disambiguated record
David S. Block
Also filed as: BLOCK DAVID · BLOCK DAVID E · BLOCK DAVID S
17 granted patents·19 pending applications·157 citations·filing 2001–2024
94Inventor score
Top patents by PatentIndex Score
36 records- 0197US10941191B2Immunoglobulin constant region Fc receptor binding agentsUNIV MARYLAND·Filed 2018·Granted Mar 9, 2021·8 cites·23 claims
- 0296US10851154B2Immunoglobulin constant region Fc receptor binding agentsUNIV MARYLAND·Filed 2016·Granted Dec 1, 2020·8 cites·12 claims
- 0396US9926362B2Immunoglobulin constant region Fc receptor binding agentsUNIV MARYLAND·Filed 2017·Granted Mar 27, 2018·16 cites·25 claims
- 0496US8680237B2Immunoglobulin constant region FC receptor binding agentsSTROME SCOTT E·Filed 2008·Granted Mar 25, 2014·47 cites·15 claims
- 0595US10208105B2Immunoglobulin constant region Fc receptor binding agentsUNIV MARYLAND·Filed 2018·Granted Feb 19, 2019·12 cites·20 claims
- 0694US11117940B2Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin Fc compositionsGLIKNIK INC·Filed 2017·Granted Sep 14, 2021·6 cites·18 claims
- 0794US9512210B2Immunoglobulin constant region Fc receptor binding agentsUNIV MARYLAND·Filed 2014·Granted Dec 6, 2016·17 cites·12 claims
- 0894US9512208B2Immunoglobulin constant region FC receptor binding agentsUNIV MARYLAND·Filed 2013·Granted Dec 6, 2016·15 cites·2 claims
- 0991US11331372B2Methods of treating inflammatory disorders with multivalent Fc compoundsGLIKNIK INC·Filed 2017·Granted May 17, 2022·5 cites·19 claims
- 1091US9683044B2Molecules with antigen binding and polyvalent FC gamma receptor binding activityGLIKNIK INC·Filed 2013·Granted Jun 20, 2017·14 cites·13 claims
- 1190US11034775B2Cysteine-optimized stradomersGLIKNIK INC·Filed 2017·Granted Jun 15, 2021·5 cites·14 claims
- 1288US11795193B2Manufacturing optimization of GL-2045, a multimerizing stradomerGLIKNIK INC·Filed 2021·Granted Oct 24, 2023·1 cites·20 claims
- 1385US12195499B2Manufacturing optimization of GL-2045, a multimerizing stradomerGLIKNIK INC·Filed 2023·Granted Jan 14, 2025·0 cites·18 claims
- 1485US11155574B2Manufacturing optimization of GL-2045, a multimerizing stradomerGLIKNIK INC·Filed 2017·Granted Oct 26, 2021·2 cites·28 claims
- 1584US2025326787A1Manufacturing optimization of gl-2045, a multimerizing stradomerGLIKNIK INC·Filed 2024·Application pending·0 cites
- 1683US2024383951A1FUSION PROTEINS OF NATURAL HUMAN PROTEIN FRAGMENTS TO CREATE ORDERLY MULTIMERIZED IMMUNOGLOBULIN Fc COMPOSITIONSGLIKNIK INC·Filed 2024·Application pending·0 cites
- 1779US12122836B2Fusion proteins of human protein fragments to create orderly multimerized immunoglobulin Fc compositions with enhanced complement bindingGLIKNIK INC·Filed 2018·Granted Oct 22, 2024·1 cites·10 claims
- 1878US2021277091A1Immunoglobulin constant region fc receptor binding agentsUNIV MARYLAND·Filed 2021·Application pending·0 cites
- 1977US12337026B2Methods of treating inflammatory disorders with multivalent Fc compoundsGLIKNIK INC·Filed 2022·Granted Jun 24, 2025·0 cites·20 claims
- 2077US12084482B2Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin Fc compositionsGLIKNIK INC·Filed 2021·Granted Sep 10, 2024·0 cites·15 claims
- 2177US2025011433A1Fusion proteins of human protein fragments to create orderly multimerized immunoglobulin fc compositions with enhanced complement bindingGLIKNIK INC·Filed 2024·Application pending·0 cites
- 2274US2024074478A1Compositions including filamentous fungal biomass and cultured animal cells, and methods of forming and usingUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 2372US2024262898A1Fusion proteins of human protein fragments to create orderly multimerized immunoglobulin fc compositions with enhanced fc receptor bindingGLIKNIK INC·Filed 2023·Application pending·0 cites
- 2465US2014335075A1Immunoglobulin constant region fc receptor binding agentsGLIKNIK INC·Filed 2013·Application pending·0 cites
- 2563US2016280768A1Immunoglobulin constant region fc receptor binding agentsUNIV MARYLAND·Filed 2016·Application pending·0 cites
- 2661US2012309941A1Immunoglobulin constant region fc receptor binding agentsSTROME SCOTT E·Filed 2012·Application pending·0 cites
- 2761US2023181700A1Ace2 fc fusion proteins and methods of useGLIKNIK INC·Filed 2022·Application pending·0 cites
- 2858US2013156765A1FUSION PROTEINS OF NATURAL HUMAN PROTEIN FRAGMENTS TO CREATE ORDERLY MULTIMERIZED IMMUNOGLOBULIN Fc COMPOSITIONSBLOCK DAVID S·Filed 2011·Application pending·0 cites
- 2957US2023242672A1Ace2-fc fusion proteins and methods of useGLIKNIK INC·Filed 2021·Application pending·0 cites
- 3050US2014370012A1Fusion proteins comprising igg2 hinge domainsGLIKNIK INC·Filed 2013·Application pending·0 cites
- 3148US2019389941A1Fusion proteins of human protein fragments to create orderly multimerized immunoglobulin fc compositions with enhanced fc receptor bindingGLIKNIK INC·Filed 2017·Application pending·0 cites
- 3247US2018094061A1Molecules with antigen binding and polyvalent fc gamma receptor binding activityGLIKNIK INC·Filed 2017·Application pending·0 cites
- 3346US2017008951A1Fusion proteins comprising igg2 hinge domainsGLIKNIK INC·Filed 2016·Application pending·0 cites
- 3439US2018282424A1Molecules with bimodal activity depleting target at low dose and increasing immunosuppression at higher doseGLIKNIK INC·Filed 2015·Application pending·0 cites
- 3535US2012121578A1Methods of using immunoglobulin aggregatesBLOCK DAVID·Filed 2010·Application pending·0 cites
- 3631US2002159980A1Benomyl tolerant fusarium lateritium and uses thereofFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David S. Block files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →